Management of ulcerative colitis: where are we at and where are we heading?
Adnan Abbas,David M. P. Di Fonzo,Panu Wetwittayakhlang,Reem Al-Jabri,Peter L. Lakatos,Talat Bessissow
DOI: https://doi.org/10.1080/17474124.2024.2422370
2024-11-09
Expert Review of Gastroenterology & Hepatology
Abstract:Introduction Remission rates for ulcerative colitis (UC) remain low despite significant progress in disease understanding and the introduction of novel therapeutic agents. Several challenges contribute to this, including the heterogeneity of the disease, suboptimal efficacy of current diagnostic and therapeutic tools, drug safety concerns, and limited access to newer treatment options.
gastroenterology & hepatology
What problem does this paper attempt to address?